These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 19012177

  • 1. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target.
    Gurbel PA, Antonino MJ, Bliden KP, Dichiara J, Suarez TA, Singla A, Tantry US.
    Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177
    [Abstract] [Full Text] [Related]

  • 2. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):657-66. PubMed ID: 17291930
    [Abstract] [Full Text] [Related]

  • 3. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
    Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Mielot C, Bali L, Lambert M, Alessi MC, Bonnet JL.
    Thromb Haemost; 2007 Feb 13; 97(2):282-7. PubMed ID: 17264958
    [Abstract] [Full Text] [Related]

  • 4. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study.
    Gianetti J, Parri MS, Sbrana S, Paoli F, Maffei S, Paradossi U, Berti S, Clerico A, Biagini A.
    Thromb Res; 2006 Feb 13; 118(4):487-93. PubMed ID: 16343603
    [Abstract] [Full Text] [Related]

  • 5. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study.
    Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US.
    J Am Coll Cardiol; 2005 Nov 15; 46(10):1820-6. PubMed ID: 16286165
    [Abstract] [Full Text] [Related]

  • 6. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA.
    Rev Cardiovasc Med; 2006 Nov 15; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.
    Thromb Haemost; 2010 Aug 15; 104(2):279-86. PubMed ID: 20508896
    [Abstract] [Full Text] [Related]

  • 10. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
    Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N.
    Thromb Haemost; 2010 Jan 15; 103(1):151-9. PubMed ID: 20062919
    [Abstract] [Full Text] [Related]

  • 11. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
    Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G.
    J Am Coll Cardiol; 2008 Sep 30; 52(14):1128-33. PubMed ID: 18804738
    [Abstract] [Full Text] [Related]

  • 12. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F, Patti G, Barbato E, Peace AJ, Ricottini E, Vizzi V, Gatto L, D'Ambrosio A, De Bruyne B, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2012 Mar 30; 5(3):281-9. PubMed ID: 22440493
    [Abstract] [Full Text] [Related]

  • 13. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ, Bernardo E, Palazuelos J, Desai B, Weisberg I, Alfonso F, Guzman LA, Hernández-Antolin R, Zenni MZ, Macaya C, Fernandez-Ortiz A, Bass TA.
    Thromb Haemost; 2008 Jan 30; 99(1):161-8. PubMed ID: 18217149
    [Abstract] [Full Text] [Related]

  • 14. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ, Bernardo E, Sabaté M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolin R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A.
    J Am Coll Cardiol; 2007 Oct 16; 50(16):1541-7. PubMed ID: 17936152
    [Abstract] [Full Text] [Related]

  • 15. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
    Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Carvajal J, Lehmann A, Lambert M, Bonnet JL, Alessi MC.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1339-45. PubMed ID: 17010792
    [Abstract] [Full Text] [Related]

  • 16. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG.
    Thromb Haemost; 2008 Nov 03; 100(5):829-38. PubMed ID: 18989527
    [Abstract] [Full Text] [Related]

  • 17. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome.
    Frere C, Cuisset T, Quilici J, Camoin L, Carvajal J, Morange PE, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC.
    Thromb Haemost; 2007 Oct 03; 98(4):838-43. PubMed ID: 17938809
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
    Yong G, Rankin J, Ferguson L, Thom J, French J, Brieger D, Chew DP, Dick R, Eccleston D, Hockings B, Walters D, Whelan A, Eikelboom JW.
    Am Heart J; 2009 Jan 03; 157(1):60.e1-9. PubMed ID: 19081397
    [Abstract] [Full Text] [Related]

  • 20. The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation.
    Siller-Matula JM, Haberl K, Prillinger K, Panzer S, Lang I, Jilma B.
    Thromb Res; 2009 Apr 03; 123(6):874-80. PubMed ID: 19135705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.